Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
| Brand name | METOPROLOL SUCCINATE |
| Generic name | METOPROLOL SUCCINATE |
| Active ingredient(s) | METOPROLOL SUCCINATE |
| Distributed by / for | CARDINAL HEALTHCARE |
| NDC | 45963-676-96 |
| Full product label | Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 1000 Tablets, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454. NDC: 45963-676-96 |
| Recalling firm | CARDINAL HEALTHCARE |
| Distribution | Nationwide USA |
| Quantity | 1 unit |
| Recall initiated | 2022-01-26 |
| Report date | 2024-01-03 |
| Recall completed | 2024-09-29 |
| Recall number | D-0191-2024 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Dublin OH United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗